etanidazole has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies
Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilder, RB | 1 |
| McGann, JK | 1 |
| Sutherland, WR | 1 |
| Waller, EK | 1 |
| Minchinton, AI | 1 |
| Goris, ML | 1 |
| Knox, SJ | 1 |
1 other study available for etanidazole and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Etanidazole; Humans; Lymphoma, Non-Hodgki | 1994 |